Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metformin targets RRM2/GSS/GPX4 axis to induce fibroblast ferroptosis: A foreground strategy against hypertrophic scarring. | Free Radic Biol Med | 2026 | 41619824 | PubTator, text mining | PubMed |
| A system-level metastable model of cancer evolution: integrating replication stress, cell cycle deregulation and chromosomal instability. | Ann Med | 2026 | 41606986 | PubTator, text mining | PubMed |
| Regulation of ferroptosis in colorectal cancer through therapeutic modulation and miRNA targeting. | Biochem Biophys Rep | 2026 | 41561226 | PubTator, text mining | PubMed |
| Semantic-enhanced heterogeneous graph learning for identifying ncRNAs associated with drug resistance. | Bioinformatics | 2026 | 41533702 | PubTator, text mining | PubMed |
| Decoding adipocyte heterogeneity through single-nucleus transcriptomics unveils subtype-specific adipocytes orchestrate immunosuppressive niches in breast cancer. | J Immunother Cancer | 2026 | 41529909 | PubTator, text mining | PubMed |
| RNA-Binding Proteins in Dinoflagellates. | Int J Mol Sci | 2026 | 41516343 | PubTator, text mining | PubMed |
| Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. | Elife | 2026 | 41498402 | PubTator, text mining | PubMed |
| CAP1-Mediated m6A modification of RRM2 suppresses tumor-associated M2 macrophage polarization and colorectal cancer growth. | Cell Mol Life Sci | 2026 | 41483049 | PubTator, text mining | PubMed |
| Reprogramming SREBP1-dependent lipogenesis and inflammation in high-risk breast with licochalcone A: A novel path to cancer prevention. | Int J Cancer | 2026 | 41310893 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Gene Expression and Biomarkers in Sepsis Using Bioinformatics, Network Pharmacology and Molecular Modeling Approaches. | Biotechnol Appl Biochem | 2026 | 40926543 | PubTator, text mining | PubMed |
| Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia. | ASPET Discov | 2025 | 42422326 | PubTator, text mining | PubMed |
In Silico Transcriptomic Analysis for Identification of Potential Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Cervical Cancer using a Hybrid Genetic Algorithm-Support Vector Machine Approach. | Arch Iran Med | 2025 | 41852002 | PubTator, text mining | PubMed |
| Network-based insights into miR-30a-5p-mediated regulation and EGCG targeting in triple-negative breast cancer. | Front Bioinform | 2025 | 41487287 | PubTator, text mining | PubMed |
| Decoding protein dynamics with limited proteolysis coupled to mass spectrometry: A comprehensive review. | J Pharm Anal | 2025 | 41487146 | PubTator, text mining | PubMed |
| Integrated transcriptomic and single-cell analysis reveals cell cycle dysregulation and cellular heterogeneity in lung cancer. | Discov Oncol | 2025 | 41467951 | PubTator, text mining | PubMed |
| Integrating multi-omics data and machine learning to identify endocrine disrupting chemicals targeting key ccRCC-related genes. | Discov Oncol | 2025 | 41467947 | PubTator, text mining | PubMed |
| A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome. | Biomed Res Int | 2025 | 41439111 | PubTator, text mining | PubMed |
| Blood gene expression network expression strongly relates to brain amyloid burden. | Alzheimers Dement | 2025 | 41416491 | PubTator, text mining | PubMed |
| Unravelling TPX2-centered co-expression networks as key drivers of aggressive prostate cancer. | Sci Rep | 2025 | 41402347 | PubTator, text mining | PubMed |
| Targeting E2F8 sensitizes gemcitabine-resistant gallbladder cancer to PARP inhibitors by disrupting RRM2-driven DNA repair. | J Exp Clin Cancer Res | 2025 | 41392282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=6